Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
5.70
-0.31 (-5.16%)
At close: Dec 12, 2025, 4:00 PM EST
5.75
+0.05 (0.88%)
After-hours: Dec 12, 2025, 7:52 PM EST
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $294.3 million as of December 12, 2025. Its market cap has increased by 385.22% in one year.
Market Cap
294.30M
Enterprise Value
164.32M
1-Year Change
385.22%
Ranking
Category
Stock Price
$5.70
Market Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $294.30M, an increase of 69.96%. That is a compound annual growth rate of 9.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 294.30M | 16.10% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | 271.44M | 56.76% |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |